publication date: Dec. 19, 2010

In this issue: 

ASCO must be an “independent voice” for cancer patients and physicians, new EVP Allen Lichter says.

Also Bristol-Myers Squibb under federal investigation over Plavix deal.

Senate committee schedules hearing for FDA acting commissioner von Eschenbach.

Bush appoints seven to NCAB, designates Runowicz as chairman.

IOM report recommends solutions to problem of medication errors.

Jury finds USC geneticist William French Anderson guilty of sexual abuse of a child.

Download (PDF 470KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.